Beximco Assignment of Strategic Management

8/13/2019 Beximco Assignment of Strategic Management

http://slidepdf.com/reader/full/beximco-assignment-of-strategic-management 1/22

Submitted To:

Dr. Sibyl Noman Khan

Course Instructor (MBA 550)

Strategic Management

Department of Business AdministrationSchool of BusinessSchool of Business

Submitted By:

Date of submission: 23rd November, 2010



“BEXIMCO

PHARMACEUTICALS LTD” ~

COMPANY BEFORE & AFTER

FIVE (05) YEARS

STRATEGY.

Date of submission: 23rd November, 2010

2



Table of Contents

Topic Page No

Company Background………………………………………………………………4-5

perationa! rganogram"…………………………………………………………""#

$roduct %ine……………………………………………""""""""…………………"""""""&-'0

• ea!t * $ersona! Care"""…………………""""""""""""""""……………"" +-,

•

oods………………………………………………………"""""……"",-'0

Strategy……"………………………………………………………………………''-',

• Be.ore i/e ears Strategy……………"……"""""""""""""""""""………"""''-'2

• A.ter i/e ears Strategy …………"""…"""""""""""""""""""……………""'1-'4

• $resent Strategies……………………"""""""………………………"""'5-',

at I %earned……………………………………………………………………""20

Conc!usion …………………""……………………………………………………""2'

1



C O M P A N Y B A C K G R O U N D A B O U TC O M P A N Y B A C K G R O U N D A B O U T

B E X I M C O P H A R M A C E U T I C A L S L T D .B E X I M C O P H A R M A C E U T I C A L S L T D .

Be3imco $armaceutica!s %td" is a !eading edge parmaceutica! company and is a

memer o. te B6IMC 7roup8 te !argest pri/ate sector industria! cong!omerate in

Bang!ades" 9e strategic strengts o. Be3imco $arma are its strong rand recognition8

ig!y ski!!ed :ork .orce and di/ersi.ied usiness mi3" Be3imco $arma rands -

;eoceptin < (<anitidine)8 ;apa ($aracetamo!)8 Amdoca! (Am!odipine)8 ;eo.!o3in(Cipro.!o3acin)8 Be3itro! (Sa!metero! $!us !uticasone)8 Be3trum 7o!d (Mu!ti/itamin

and Mu!ti Minera!) and Ato/a (Ator/astatin) are among te most recogni=ed rands in

te Bang!ades $armaceutica! industry"

Be3imco $arma started its operation in ',+08 manu.acturing products under te !icenses

o. Bayer A7 o. 7ermany and >p?on Inc" o. >SA and no: as gro:n to ecome

nation@s one o. te !eading parmaceutica! companies8 supp!ying '5 o. country@s tota!

medicine need" 9oday Be3imco $arma manu.actures and markets its o:n randed

generics@ .or a!most a!! disease ranking .rom AIS to cancer8 .rom in.ection to astma8

.rom ypertension to diaetes8 ot nationa!!y and internationa!!y"

Be3imco $arma manu.actures a range o. dosage .orms inc!uding ta!ets8 capsu!es8 dry

syrup8 po:der8 cream8 ointment8 suppositories8 !arge /o!ume intra/enous .!uids8 metered

dose ina!ers etc" in se/era! :or!d-c!ass manu.acturing p!ants8 ensuring ig Dua!ity

standards comp!ying :it te or!d ea!t rgani=ation () appro/ed current 7ood

Manu.acturing $ractices (c7M$)"

9e recipient o. tree times go!d@ nationa! e3port tropy8 Be3imco $arma is te !argest

e3porter o. parmaceutica!s .rom Bang!ades8 spreading its presence in many de/e!oping

4



and de/e!oped countries across te g!oe" Be3imco $arma is te on!y company in

Bang!ades to recei/e tis igest nationa! acco!ade .or e3port8 .or record tree times"

Be3imco $arma markets its rands troug pro.essiona! sa!es and marketing teams in

A.rican8 Asian and uropean markets" It a!so supp!ies its products to reno:ned ospita!s

and institutions in many countries8 inc!uding <a..!es ospita! and E E omen *

Ci!dren ospita! in Singapore8 MS and Eenyatta ;ationa! ospita! (E;) in Eenya8

Finna ospita!8 Aga Ean ospita! and Saukat Eanum Memoria! ospita! in

$akistan" Be3imco $arma is a!so an en!isted supp!ier o. and>;IC"

Anoter important usiness acti/ity o. Be3imco $arma is te contract manu.acturing .or

ma?or internationa! rands o. !eading mu!tinationa! companies"

Be3imco $arma is acc!aimed domestica!!y and internationa!!y .or its outstanding

product Dua!ity8 :or!d c!ass manu.acturing .aci!ities8 product de/e!opment capai!ities

and outstanding ser/ice"

Be3imco $arma as a strong market .ocus and is anticipating continued .uture gro:t

y !e/eraging usiness capai!ities and de/e!oping superior product rands and markets"

In particu!ar te company is /ery interested in de/e!oping a strong e3port market in >SA

and urope" 9o meet te .uture demand Be3imco $arma as in/ested >SG 50 mi!!ion to

ui!d a ne: state-o.-te-art manu.acturing p!ant8 con.irming to >SA and >E M<A

standards" 9is ne: p!ant :i!! a!so o..er contract-manu.acturing .aci!ity to !eading

parmaceutica! companies8 especia!!y .rom urope and >S"

5



O R G A N I Z A T I O N A L O R G A N O G R A MO R G A N I Z A T I O N A L O R G A N O G R A M

#



P R O D U C T L I N EP R O D U C T L I N E

&



A!"#$% D$'"!"

Be3imco $arma as a strong .ocus to o..er treatment so!utions .or ot seasona! and

perennia! a!!ergic rinitis" 9e ?ourney o. Be3imco $arma in tis arena egan :it te

!icensing arrangement :it Bayer A7 o. 7ermany .or te manu.acture and marketing o.

Incida!H in Bang!ades " $roducts in tis category a!so inc!ude a proprietary drug8

de/e!oped y te < * team at Be3imco $arma and pro/ides 24-our re!ie. o. a!!ergic

rinitis :it congestion (marketed under te rand name - $retinH ) Be3imco $arma

:i!! continue to ui!d on its tradition o. !auncing te generic /ersions o. a!! te researc

mo!ecu!es in tis category"

A*#!$% & A+$,-"!+$%

Be3imco $arma is te !argest pro/ider o. ana!gesic medicines in Bang!ades8 !ed y te

strong per.ormance o. ;apaH8 a preparation o. paracetamo!" $aracetamo! is te sa.est

ana!gesic in te :or!d .or more tan 50 years" ;apa is te numer one rand in terms o.

unit sa!es in Bang!ades and is a/ai!a!e in '1 .orms and strengts"

A+$$/!%+$!

Be3imco $arma is one o. te !eading companies in te .ie!d o. antiacteria! and anti/ira!

treatments o..ering a :ide range o. products" 9e anti-in.ecti/e products o. Be3imco

$arma are o..ered in di..erent dosage .orms 9a!et8 Capsu!e8 %arge /o!ume and Sma!!

/o!ume parentera!s .or systemic administration and Cream and intment .or topica!

administration" Be3imco $arma is te on!y company is Bang!ades to manu.acture

anti/ira! products to treat most serious in.ections o. IJ (AIS)"

E-! C*"!

+



Be3imco $armaceutica!s %td as introduced its /ision unit in te year 200," ;o:

Be3imco $arma got around 20 opta!mic products in its product range co/ering

/arious 9erapeutic groups !ike Anti-in.ecti/e8 Anti-in.!ammatory8 Arti.icia! 9ear8 Anti-

a!!ergic8 Anti-g!aucoma and eye /itamins and minera!s etc" Continuous enricment o.

opta!mic product range is going on"

C*"$'*%1*"

Be3imco $arma as a!:ays een te !eader in Bang!ades cardio/ascu!ar market :it

inno/ati/e product o..erings to treat a!most a!! type o. cardio/ascu!ar diseases !ike

ypertension8 Coronary Artery iseases8 yper!ipidemia8 eart ai!ure8 Arrytmia etc"

Be3imco $arma@s am!odipine rand Amdoca!H is te numer ' cardio/ascu!ar rand

since ',,#"

C!+"* N!"'1 S-+!2

Be3imco $arma as a :ide range o. C;S medication pro/ide e..ecti/e treatment o.

di..erent diseases in/o!/ing C;S inc!uding an3iety8 depression8 migraine8 epi!epsy8

insomnia8 sci=oprenia8 dementia etc"

C'1#3 & C'

ide product range o. Be3imco $arma o..ers te doctors .reedom to coose te rigt

medication .or di..erent types o. coug dry coug8 cesty producti/e coug and oter

coug associated :it common co!d"

E'%"$! & D$*4!+!

,



Be3imco $arma o..ers :ide range o. products ensuring e..ecti/e treatment o. type II

diaetes" It as te generic /ersions o. a!! te !eading researc mo!ecu!es inc!uding

7!ipi=ide8 7!ic!a=ide8 Met.ormin8 7!imepiride8 $iog!ita=one <epag!inide etc"

M1%'!!+*

steoartritis8 <eumatoid artritis8 Musc!e spasm8 pain o. muscu!oske!eta! origin are

some o. te diseases tat !imit te acti/ities o. dai!y !i.e o. mi!!ions o. patients" Be3imco

$arma :it its :ide range o. products in te muscu!oske!eta! category o..ers e..ecti/e

treatment so!ution .orr tose patients

O%''#-

Be3imco $arma manu.actures a generic /ersion o. 9amo3i.en (9amona H) :ic is

eing used success.u!!y :or!d :ide .or te treatment o. reast cancer disease" 9e

company a!so as a pro/en drug .or te treatment o. nausea and /omiting associated :it

cancer terapy"

V$+*2$ & M$!"* S1,,!2!+

Be3imco $arma@s many rands in te /itamins and nutritiona! supp!ement category as

gained trust o. te pysicians in treating /arious /itamins and nutritiona! de.iciency

symptoms"

R!,$"*+'"-

'0



Be3imco $arma is te !eading manu.acturer o. pressuri=ed Metered ose Ina!ers

(MI) in Bang!ades and are among te .e: companies in te :or!d manu.acturing CC

(C!oro.!uorocaron) .ree MIs" It as a :ide range o. ina!ers @<e!ie/er@8 @$re/enter@ and

@Contro!!er@ .or te treatment o. astma and C$" 9e company a!so undertakes

contract manu.acturing .or 7!a3oSmitE!ine .or its @re!ie/er@ rand" In co!!aoration :it

urope@s one o. te !eading manu.acturers o. specia!ty medica! de/ices and respiratory

drug de/e!opment companies8 Be3imco $arma success.u!!y de/e!oped and introduced

country@s .ist CC-.ree A ased MIs in Septemer 200#"

S$ C*"!

Be3imco $arma@s roust product !ine in te skin care category o..ers easy and

con/enient so!ution to :ide range o. skin diseases !ike .unga! and acteria! in.ections8

ec=ema8 atopic dermatitis8 oter in.!ammatory skin diseases reDuiring corticosteroid

terapy8 acne8 psoriasis8 and /arious oter dry skin pro!ems"

B E F O R E F I V E Y E A R S S T R A T E G YB E F O R E F I V E Y E A R S S T R A T E G Y

''



C'"! V*1!

9rust and re!iai!ity to te products emerged as one o. te core /a!ues o. Be3imco

$armaceutica!s %imited" It maintains Dua!ity in manu.acturing o. products according to

te ru!es o. te " iring a competent ranc o. peop!e :o are est in teir capacity

to ser/e te company est8 strengten te B$% .unction o. operation "It a!so gi/e

empasi=e on promoting ne: products troug researc and ringing cost e..iciency in

usiness operations"

Be3imco $arma e!ie/es tat it is in te usiness :ic dea!s :it uman ea!t :ic

makes it more responsi!e to keep te igest standards o. its products" 9roug its products it tries to de!i/er c!ear ene.its to te patients"

7ood products8 o:e/er8 are on!y one side o. its e3pression o. commitment" B$%

e!ie/es its responsii!ity !ies e/en more in ensuring tat te society gets ene.ited :i!e

it continues to gro:"

C'",'"*+! S'%$* R!,'$4$$+$!

Corporate socia! responsii!ity is an integra! part o. B$%Ks usiness strategy :ic is

re.!ected in its mission statement" /ery emp!oyee o. te company kno:s tat te

company does not /ie: its success and acie/ements in .inancia! terms on!y8 ut a!so in

terms o. its deep re!ationsip :it te society"

ac year8 an increasing amount o. contriution is p!ouged ack into socia! causes8

demonstrating Be3imco $arma@s commitment to te nation" More important!y te

company@s contriution e3tends eyond one-time donation to ongoing participation as

re.!ected in its partnersip :it ;7s :orking .or AIS patients8 in supporting sports8

and in raising disease a:areness among te peop!e"

'2



B$% donated medicines :ort mi!!ions o. taka to /ictims in nationa! and internationa!

ca!amities" onation o. medicines to /ictims o. eartDuake in $akistan and /ictims o.

tsunami in Sri %anka are :ort mentioning"

9e company maintains a team o. scientists :o :orks as parmaceutica! e3perts .or

good go/ernance tat gi/e direct ene.it to te common peop!e and sareo!ders"

Be3imco $armaceutica!s %imited care.u!!y designed its .aci!ities .or reducing a=ardous

impact on te en/ironment troug operationa! e3ce!!ence pro/iding a .riend!y

en/ironment .or a ea!ty society .or tomorro: eing te main responsii!ity o. B$%"

A F T E R F I V E Y E A R S S T R A T E G YA F T E R F I V E Y E A R S S T R A T E G Y

'1



M*1/*%+1"$# F*%$$+$!

%ocated at 9ongi8 near te capita! city aka8 B$%Ks manu.acturing site is spread o/er an

area o. 20 acres :ic ouses a numer o. se!. contained production units inc!uding ora!

so!ids8 metered dose ina!ers8 intra/enous .!uids8 !iDuids8 ointments8 creams8

suppositories8 opta!mic drops8 in?ecta!es8 neu!i=er so!utions etc" 9e u!k drug unit

.or producing paracetamo! is a!so !ocated :itin tis site" CompanyKs penici!!in A$I and

.ormu!ation units are situated at Ea!iakoir8 a .e: kms .rom te main site"

9e p!ant and macinery trougout te site a/e een designed y and procured most!y

.rom reno:ned uropean companies"

Be3imco $arma as its o:n uti!ity in.rastructure to ensure adeDuate generation and

distriution o. puri.ied :ater at a!! times" 9e insta!!ed capacity o. po:er generation is +

M" 9ere is a!so !iDuid nitrogen generation .aci!ity on site"

61*$+- P'$%-

Be3imco $armaceutica! %imited@s mission is to acie/e usiness e3ce!!ence troug

Dua!ity y understanding8 accepting8 meeting and e3ceeding customer e3pectations"

Be3imco $armaceutica! %imited (B$%) .o!!o:s Internationa! Standards on Lua!ity

Management System to ensure consistent Dua!ity o. products and ser/ices to acie/e

customer satis.action" B$% a!so meets a!! nationa! regu!atory reDuirements re!ating to its

current usinesses and ensures tat current 7ood Manu.acturing $ractices (c7M$) as

recommended y or!d ea!t rgani=ation is .o!!o:ed .or its parmaceutica!operations"

9e management o. B$% commits itse!. to Dua!ity as te prime consideration in a!! its

usiness decisions" A!! emp!oyees o. B$% must .o!!o: documented procedures to ensure

comp!iance :it Dua!ity standards"

'4



9e poo! o. uman resources o. te company :i!! e de/e!oped to teir .u!! potentia! and

arnessed troug regu!ar training and teir participation in seeking continuous

impro/ement o. :ork metods"

E$"'2!+* P'$%-

B$% is committed to maintain te armonious a!ance o. our eco-system and tere.ore

constant!y seeks :ays to manu.acture and produce products in an eco-.riend!y manner so

tat te a!ance o. nature remains undistured and te en/ironment remains sustaina!e"

In pursuit o. tis goa!8 B$% :i!! comp!y .u!!y :it a!! !oca! and nationa! en/ironmenta!

regu!ations"

Conser/e natura! resources !ike :ater and energy .or sustaina!e de/e!opment8 and adopt

en/ironmenta!!y sa.e processes"

nsure appropriate treatment o. a!! e..!uents prior to discarge8 to pre/ent po!!ution or

degradation o. en/ironment"

nsure appropriate communication and cooperate :it interna! and e3terna! interested

parties on en/ironmenta! issues"

Create a:areness on en/ironmenta! issues among our emp!oyees and supp!iers"

Adopt modern :aste management tecno!ogy"

P R E S E N T S T R A T E G I E SP R E S E N T S T R A T E G I E S

'5



MARKET PO!"#

D'2!+$% M*"!+

Being a de/e!oping country8 te parmaceutica! market and at te same time8 te

parmaceutica! industry o. Bang!ades is gro:ing" In tis gro:ing market8 B$% as een

a!e to maintain its gro:t troug its inno/ati/e marketing strategies"

In Bang!ades8 B$% introduced te concept o. Dua!ity management system y eing te

.irst company to acie/e IS ,00' certi.ication tat re.!ects its commitment to Dua!ity in

e/ery aspect o. usiness"

B$% co/ers te ea!t care community o. :o!e Bang!ades ased in ot uran and

rura! markets8 troug its '+ strategica!!y !ocated depots"

I+!"*+$'* M*"!+

9o .ue! te continuous gro:t o. B$%8 te company as started e3p!oring internationa!

markets" 9e Dua!ity o. B$% products8 strengtened y its IS ,00' certi.ication8 as

rougt immediate success in >E8 America8 Austra!ia8 rance8 Bra=i!8 India8 $akistan8 Sri

%anka8 emen8 Myanmar and Jietnam"

R!#1*+'"- A,,"'*

'#



9e manu.acturing .aci!ities o. Be3imco $arma a/e een audited and appro/ed y

• ;ationa! ea!t Sur/ei!!ance Agency (A;JISA)8 Bra=i! (MI)

• 9erapeutic 7oods Administration (97A)8 Austra!ia (S8 MI and Spray)

• 7u!. Centra! Committee .or rug <egistration (.or 7CC memer states)(S *

MI)

• Lua!i.ied y >;IC (MI * S)

• Lua!i.ied y 7!oa! 7!a3oSmitE!ine (MI)

• Lua!i.ied y Astma rug aci!ity (A)8 rance (MI)

• Lua!i.ied y 7!oa! o.. Mann %a <oce (S)

• Appro/a!s y >E M<A and >SA are under process

• S8 ra! So!id osage MI8 Metered ose Ina!er

R!!*"%3 & D!!',2!+

it strong re/erse engineering capai!ity8 :e .ocus principa!!y on de/e!oping ig

Dua!ity generic .ormu!ations8 matcing te pro.i!e o. inno/ator products" e a!so .ocus

on simp!i.ying manu.acturing processes and impro/ing cost e..iciency" ur gro:ing

inno/ation is e/ident .rom success.u! !auncing o. a numer o. ad/anced .ormu!ations

!ike mu!ti-!ayer ta!ets8 sustained re!ease .ormu!ations8 dispersi!e ta!ets8 me!t-in mout

ta!ets8 ce:a!e /itamins etc" In proprietary researc8 :e conducted co!!aorati/e

researc :it Cia Specia!ty Cemica!s o. S:it=er!and" it ur <* team as

success.u!!y de/e!oped a range o. CC-.ree A MIs" In addition8 :e are a!so

de/e!oping a numer o. A$Is to ensure a/ai!ai!ity o. ra: materia!s across te range o.

terapeutic c!asses" ur capai!ity to produce i-tec8 specia!i=ed nice products as :e!!

as drug de!i/ery systems as een our core strengt to trans.orm B$% into an inno/ation-

dri/en generic drug company"

'&



C'",'"*+! S'%$* R!,'$4$$+-

Commitment to our society is an integra! part o. te :ay :e are doing usiness" e do

not ?udge our success in .inancia! terms on!y :e /a!ue e/en more te deep re!ationsip

:it te society :e !i/e in" ac year8 a sustantia! amount o. our earning is p!ouged

ack into socia! causes8 so tat our society gets ene.ited :i!e :e continue to gro:"

7. D'*+$' '/ 2!$%$!

e donate and make a/ai!a!e a !arge Duantity o. medicines to te /ictims o. natura!

disasters8 ot nationa! and internationa!" Medicines .or te /ictims o. eartDuake in

$akistan8 sunami in Sri %anka8 and cyc!one SI< in Bang!ades are a .e: :ort

mentioning"

8. P"'$$# T"!*+2!+ /'" AIDS ,*+$!+ $ B*#*!3

<esponding to te needs o. tousands o. AIS patients in te country8 :e are proud to e

associated :it te initiati/es to pro/ide treatment .or tese patients" Since 20058

Be3imco $arma as een supp!ying A<J drugs troug utc Bang!a Bank8 a !eading

!oca! ank8 .or treating te AIS patients in Bang!ades" 9ese A<J drugs are

distriuted troug Asar A!o8 Mukto Akas8 and Con.identia! Approac to AIS

$re/ention (CAA$) - ;7s :orking .or te IJNAIS patients

9. O!/1 +' /$#3+ *#*$+ A$* * S:$! F1

Since its !aunc in Marc 200#8 se.!u8 B$%Ks rand o. ose!tami/ir capsu!e8 as een

donated to te go/t" o. Bang!ades as :e!! as di..erent reputed organi=ations inc!uding

IC<8B in response to te pandemic A/ian as :e!! as recent S:ine !u" e a!so

supp!ied se.!uH to te go/ernment o. Myanmar as a part o. our CS< initiati/es

'+



O!"!* M*"!+

9e company is te !argest e3porter o. parmaceutica!s .rom Bang!ades and te on!y

company to recei/e ;ationa! 3port 9ropy (7o!d)8 te igest nationa! acco!ade .or

e3port8 .or record tree times" B$% as a g!oa! .ootprint in more tan 45 countries

across .our continents and current!y in te process o. entering te emerging markets o.

CIS :it increasing .ocus on regu!ated markets !ike > and >SA"

Besides te retai! out!ets8 Be3imco $armaKs products are eing supp!ied to reno:ned

ospita!s and institutions !ike <a..!es ospita! and E E omen * Ci!dren ospita! in

Singapore8 MS and Eenyatta ;ationa! ospita! (E;) in Eenya8 Finna ospita!8 and

Aga Ean ospita! in $akistan"

C'+"*%+ M*1/*%+1"$# O,,'"+1$+$!

<ising cost o. ea!tcare and medicines as ecome a g!oa! concern8 and in order to

reduce cost across te /a!ue cain8 parmaceutica! companies .rom de/e!oped markets

continue to !ook .or suita!e partners in de/e!oping countries .or si.ting or outsourcingteir production" it decades o. e3perience in generic drug manu.acturing8 :or!d c!ass

capai!ities as :e!! as signi.icant cost ad/antages8 Be3imco $arma can e an idea!

partner .or you to meet your contract manu.acturing needs" Since its inception8 Be3imco

$arma as esta!ised itse!. as a re!ia!e partner .or a numer o. :or!d@s !eading

parmaceutica! companies" 9e company as maintained a track record o. sound

pro.essiona!ism and its management as a!:ays adered to internationa! standards

pro/iding a cu!ture and :orking en/ironment simi!ar to tat o. a mu!tinationa! company"

Current!y te company as contract manu.acturing agreement :it 7!a3oSmitE!ine

(7SE) .or producing Metered ose Ina!er product" 9ese partnersips a/e pro/ided

B$% muc /a!ua!e e3pertise and kno:-o: to manu.acture :or!d-c!ass products"

9e company o..ers signi.icant cost ad/antage as a manu.acturer8 as te a/erage :age in

',



Bang!ades is proa!y te !o:est in te :or!d8 and at !east t:o to tree times !o:er tan

tat in Cina or India" $rospecti/e partners can ene.it temse!/es :it competiti/e

ad/antages !ike a/ai!ai!ity o. ig!y ski!!ed manpo:er at a /ery !o: cost8 !o: energy

cost8 7o/t" po!icy support8 in/estor .riend!y en/ironment etc"

W H A T I L E A R N E DW H A T I L E A R N E D

20



I !earned8 Be3imco $armaceutica!s %td" e!ie/ed in gro:t strategy8 sometimes troug

concentration8 sometimes integration and some eing di/ersi.ication" It started o.. :it

ori=onta! integration in ',+0 and ten it ad unre!ated di/ersi.ications" Continuing tat

ti!! ',+0Ks to 20'00 it canged its track to re!ated and speci.ic di/ersi.ication as teir

strategies and o?ecti/es s:itced to c!osure and disposa!s o. te /aried .actories in order

to restructure and cut costs" 9is inc!uded te cut do:n o. :ork.orce .rom te :orkp!ace"

o:e/er8 in a!! tese periods8 te strategies pro/ed to e ene.icia! .or te company as

tere as een a numer o. di/ersi.ications and as :e!! as .or:ard /ertica! integration

tat inc!uded te acDuiring o. Be3imco $arma manu.actures a range o. dosage .orms

inc!uding ta!ets8 capsu!es8 dry syrup8 po:der8 cream8 ointment8 suppositories8 !arge

/o!ume intra/enous .!uids8 metered dose ina!ers etc" in se/era! :or!d-c!ass

manu.acturing p!ants8 ensuring ig Dua!ity standards comp!ying :it te or!d ea!t

rgani=ation () appro/ed current 7ood Manu.acturing $ractices (c7M$)"

9e company set ne: reconstructed teir strategies Be3imco $arma :ou!d no: turn

into concentration and .ocus on teir primary !ine o. usiness8 tus cut do:n e3cess costs

.rom restructuring8 ig !e/e! o. outsourcing and a!so c!osure o. .actories In spite o. tis8

Be3imco $arma stood up y o/ercoming te ostac!e /ia retrencment strategy :ic

ensured te re/ita!i=ation o. te company resource and status"

9e company p!anned ne: strategies encompassing tat tere :ou!d e iger annua!

sa!es tus maintaining te top position in te usiness .ie!d8 more outsourcing8 rise in te

:or!d-:ide uying etc" 9roug a!! tese steps te company gained internationa! and

nationa! A:ards8 <ecognition and Consumer-9rust8 tere.ore created a ne: mi!estone in

te :or!d o. usiness"

C O N C L U S I O NC O N C L U S I O N

2'



A.ter kno:ing te :o!e strategic management tecniDues .o!!o:ed y Be3imco $arma

it is c!ear tat8 no company can .o!!o: one .orm or approac .rom te corporate !e/e!

strategy" Situations /ary and so does te usiness strategies to meet te demand at a gi/en

point o. time" o:e/er8 Be3imco $arma as a!so een tat o. a kind :ere tey

practiced di..erent types o. gro:t strategies8 reaced oom and at te same time

company .o!!o:ed to te need .or reco/ery stage :ere tey a/e gone troug te

rene:a! strategy" But more or !ess it can e said tat Be3imco $arma pre.erred eiter

gro:t troug market de/e!opments and i. not so ten stai!ity :it a consistent

approac to:ards consumer" e!! te sum up o. te case study can e stated as tat :it

a!! teir superior strategies and tecniDues tey a/e continued to stay prosperous .rom

centuries and a!so ope to maintain tat trougout"

Beximco Assignment of Strategic Management

Documents

Transcript of Beximco Assignment of Strategic Management